☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Ferring
Ferring Launches Rebyota for the Prevention of Recurrence of C. diff Infection in Adults in the US
February 15, 2023
Ferring’s Adstiladrin (nadofaragene firadenovec-vncg) Receives the US FDA’s Approval for BCG-Unresponsive Non-Muscle Invasive Blad...
January 18, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.